Abstract
Who to start, who to refer and how to monitor, from a clinic that has prescribed them for three years.
Description
Presented in “Cardiometabolic Risk: What the New Evidence Changes”.
About the Speaker
AO
Co-Speakers
SW
Sarah Whitfield
Nurse Practitioner and Clinical Educator, Coastal Health District
Q&A for GLP-1 Receptor Agonists in the Cardiology Clinic
Sign in to vote on questions.
Details
Duration30 min
RoomHall B (L2-HALL-B)
Tags
#live-day#clinical-practice
This Session
Cardiometabolic Risk: What the New Evidence Changes
1:05 pm – 2:35 pm
Hall B
2 talks in this session
View SessionOther Talks in This Session
Lower Is Better? Revisiting LDL Targets After the Latest Outcome Trials
Amara Okafor
1:05 pm – 1:35 pm